Results 1 to 10 of about 118,508 (141)

Granulomatous Fasciitis Followed by Morphea Profunda: Is Granulomatous Fasciitis Part of a Spectrum of Deep Morphea? A Case Report and Review of the Literature [PDF]

open access: yesClinical Case Reports (discontinued), 2018
Key Clinical Message Although eosinophilic fasciitis is known to be part of the deep morphea spectrum, this first report of the coexistence of granulomatous fasciitis and morphea profunda suggests that granulomatous fasciitis may also be a part of the ...
Karra A Jones   +2 more
exaly   +11 more sources

Morphea Profunda With Tertiary Lymphoid Follicles: Description of Two Cases and Review of the Literature [PDF]

open access: yesDermatopathology (Basel, Switzerland), 2022
Morphea profunda or subcutaneous (deep) morphea is a variant of localized morphea, characterized by one or more ill-defined, deep sclerotic plaque. Preferential sites are the abdomen, trunk, sacral area, or extremities.
Margherita Vannucchi
exaly   +8 more sources

Extensive Morphea Profunda With Autoantibodies and Benign Tumors: A Rare Case Report [PDF]

open access: yesIndian Dermatology Online Journal, 2012
The term deep morphea describes a variant of morphea (localised scleroderma) in which inflammation and sclerosis are found in the deep dermis, panniculus, fascia or superficial muscle. It is sometimes associated with autoantibodies. We report the case of
Leelavathy Budamakuntla
exaly   +7 more sources

Morphea Profunda Presenting as a Neuromuscular Mimic [PDF]

open access: yesJournal of Clinical Neuromuscular Disease, 2008
Abstract Localized scleroderma is characterized by idiopathic fibrosis of the skin and adjacent structures, and muscle involvement occurs predominantly in deep morphea. We report a patient with linear scleroderma who presented with slowly progressive atrophy, muscle weakness, and loss of function of her right arm ...
Sigrid Pillen   +2 more
exaly   +5 more sources

Morphea profunda masquerading as prurigo nodularis: An uncommon presentation

open access: yesIndian Journal of Dermatology, 2022
Angoori G Rao   +4 more
doaj   +4 more sources

Successful tocilizumab-based combination therapy for a case of rapidly progressive adult deep morphea with multiple antiphospholipid antibodies: a case report and literature review [PDF]

open access: yesFrontiers in Immunology
BackgroundLocalized Scleroderma (LoS), particularly aggressive subtypes such as Deep Morphea (morphea profunda), is a rare chronic autoimmune fibrosing disorder that can extend into the subcutaneous tissue, fascia, and muscle.
Ruohan Yu   +8 more
doaj   +2 more sources

Dupilumab for the Treatment of Cutaneous Immune-Related Adverse Events: A Systematic Review. [PDF]

open access: yesInt J Dermatol
ABSTRACT The emergence of immune checkpoint inhibitors has revolutionized the landscape of cancer treatment in the modern era. However, cutaneous immune‐related adverse events (cirAEs) are common, significantly affecting patients' quality of life and often leading to treatment discontinuation, which may compromise oncological outcomes.
Koumprentziotis IA   +5 more
europepmc   +2 more sources

Sklerosierende Erkrankungen der Haut [PDF]

open access: yesJ Dtsch Dermatol Ges
Zusammenfassung Sklerosierende Hautkrankheiten sind eine Gruppe unterschiedlicher dermatologischer Erkrankungen, die durch fibrotische Veränderungen gekennzeichnet sind und die Lebensqualität der Patienten stark einschränken können. Diese Erkrankungen treten häufig mit kutanen Manifestationen auf und können in bestimmten Fällen auch extrakutanes Gewebe
Kalantari Y   +4 more
europepmc   +2 more sources

Clinical evaluation of a 31-year-old woman with crural monomelic amyotrophy. [PDF]

open access: yesClin Case Rep, 2020
This report describes the clinical presentation of a female patient diagnosed with crural MMA. Careful clinical correlation is necessary to distinguish crural MMA from other motor neuron diseases. When crural MMA is diagnosed, treatment options aim to alleviate symptoms.
Thompson AR, Beckett B, Ensrud ER.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy